TSX News -
U.S. FDA Approves Spectral’s Third PMA Module for Its Toraymyxin(TM) Treatment of Endotoxemic Septic Shock
TORONTO, ONTARIO–(Marketwired – March 7, 2017) – Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a Phase III company developing […]